Anti-PPP1R3F monoclonal antibody

Pre-made anti-PPP1R3F monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PPP1R3F/PPP1R3F products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1438-Ab-1/ GM-Tg-hg-IP1438-Ab-2Anti-Human PPP1R3F monoclonal antibodyHuman
GM-Tg-rg-IP1438-Ab-1/ GM-Tg-rg-IP1438-Ab-2Anti-Rat PPP1R3F monoclonal antibodyRat
GM-Tg-mg-IP1438-Ab-1/ GM-Tg-mg-IP1438-Ab-2Anti-Mouse PPP1R3F monoclonal antibodyMouse
GM-Tg-cynog-IP1438-Ab-1/ GM-Tg-cynog-IP1438-Ab-2Anti-Cynomolgus/ Rhesus macaque PPP1R3F monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1438-Ab-1/ GM-Tg-felg-IP1438-Ab-2Anti-Feline PPP1R3F monoclonal antibodyFeline
GM-Tg-cang-IP1438-Ab-1/ GM-Tg-cang-IP1438-Ab-2Anti-Canine PPP1R3F monoclonal antibodyCanine
GM-Tg-bovg-IP1438-Ab-1/ GM-Tg-bovg-IP1438-Ab-2Anti-Bovine PPP1R3F monoclonal antibodyBovine
GM-Tg-equg-IP1438-Ab-1/ GM-Tg-equg-IP1438-Ab-2Anti-Equine PPP1R3F monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1438-Ab-1/ GM-Tg-hg-IP1438-Ab-2; GM-Tg-rg-IP1438-Ab-1/ GM-Tg-rg-IP1438-Ab-2;
GM-Tg-mg-IP1438-Ab-1/ GM-Tg-mg-IP1438-Ab-2; GM-Tg-cynog-IP1438-Ab-1/ GM-Tg-cynog-IP1438-Ab-2;
GM-Tg-felg-IP1438-Ab-1/ GM-Tg-felg-IP1438-Ab-2; GM-Tg-cang-IP1438-Ab-1/ GM-Tg-cang-IP1438-Ab-2;
GM-Tg-bovg-IP1438-Ab-1/ GM-Tg-bovg-IP1438-Ab-2; GM-Tg-equg-IP1438-Ab-1/ GM-Tg-equg-IP1438-Ab-2
Products NameAnti-PPP1R3F monoclonal antibody
Formatmab
Target NamePPP1R3F
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PPP1R3F monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1438-Ag-1Recombinant multi-species PPR3F/ PPP1R3F/ HB2E protein


    Target information

    Target IDGM-IP1438
    Target NamePPP1R3F
    Gene ID89801,54646,363453,715950,491877,101084601,513859,100062942
    Gene Symbol and SynonymsDXImx48e,HB2E,LL0XNC01-7P3.1,PPP1R3F,R3F,RF3,RGD1566398,Sfc15
    Uniprot AccessionQ6ZSY5
    Uniprot Entry NamePPR3F_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000049769
    Target ClassificationN/A

    The target: PPP1R3F, gene name: PPP1R3F, also named as HB2E, LL0XNC01-7P3.1, R3F. This gene encodes a protein that has been identified as one of several type-1 protein phosphatase (PP1) regulatory subunits. One or two of these subunits, together with the well-conserved catalytic subunit, can form the PP1 holoenzyme, where the regulatory subunit functions to regulate substrate specificity and/or targeting to a particular cellular compartment. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.